iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Jane Street Group LLC

Jane Street Group LLC grew its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 5.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 11,846 shares of the company’s stock after purchasing an additional 616 shares during the period. Jane Street Group LLC owned approximately 0.12% of iShares U.S. Pharmaceuticals ETF worth $836,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of IHE. Pinnacle Family Advisors LLC boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 75.8% during the 3rd quarter. Pinnacle Family Advisors LLC now owns 11,595 shares of the company’s stock valued at $819,000 after purchasing an additional 5,000 shares in the last quarter. Flow Traders U.S. LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter worth approximately $839,000. FMR LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 10.9% during the third quarter. FMR LLC now owns 13,581 shares of the company’s stock worth $959,000 after buying an additional 1,338 shares in the last quarter. Thrivent Financial for Lutherans grew its position in iShares U.S. Pharmaceuticals ETF by 23.6% in the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after buying an additional 6,214 shares during the last quarter. Finally, Patten & Patten Inc. TN increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 9.5% in the third quarter. Patten & Patten Inc. TN now owns 25,813 shares of the company’s stock valued at $1,823,000 after buying an additional 2,245 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 0.6 %

Shares of IHE opened at $65.72 on Thursday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $61.14 and a 1-year high of $72.94. The stock has a market capitalization of $663.77 million, a P/E ratio of 6.49 and a beta of 0.58. The business’s 50-day moving average price is $68.04 and its 200 day moving average price is $69.02.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.